X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Research And Views Archives | Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Archives... Don't Miss Anything, Ever!

Here you will find all the research and views that we post on Equitymaster. Use the tools to customize the results to suit your preference!
















Authors
 

FMCG: The power of advertising

(Aug 4, 2009)

Equitymaster analyses how increase in advertisement spending helped consumer goods companies in the June quarter

What lower inflation means to FMCG players?

(Nov 19, 2008)

The latest statistics on inflation showed that the same has cooled off to a 6-month low and come down to single digits, primarily thanks to lower commodity prices. Since FMCG companies play a major role in driving consumption growth, which is necessary for a slowing economy, we analyse what kind of impact the inflation number can have on the FMCG sector.

Someone's nibbling at the grocery bag!

(Sep 12, 2007)

Inflation is a bane that has been imposed upon the mankind courtesy his unending greed in a world of limited resources. While there may be a debate over the fact that a steady inflation rate is good for the economy,

FMCG majors: Not way behind!

(Jun 6, 2007)

Like the midcaps, though slower, the FMCG large caps continued to sustain robust growth momentum supported by the shift from the unorganised sector, increased realisations and acquisitions. The pressure from the rising input prices was visible leading to a fall in the margins. We give you a review of the performance of the majors like ITC, Dabur, Tata Tea and Britannia for the year.

FMCG: Small is beautiful!

(Jun 16, 2005)

Yesterday we wrote about how large FMCG companies performed in FY05 in comparison to FY04 and the picture was quite bleak. Today, we compare 5 other FMCG companies, albeit this time from the mid-cap space. The five companies included here are Dabur, Godrej Consumer Products, Colgate, Marico and Pidilite.

Dabur India PAT up 28%

(Oct 27, 2004)

Dabur India has reported over 13% topline growth during the September quarter (standalone India operations). There was an improvement in operating margins led by a dip in advertising expenses as a percentage of sales. Higher other income and lower interest outgo, combined with the margin expansion led to the consequent 28% rise in net profits for the quarter. The company has restated its consolidated numbers for 2QFY04 and we have yet to receive a detailed release on the same. We will put up a d

Dabur: What to do?

(Jun 27, 2003)

Dabur India Limited has recently decided to demerge its FMCG and Pharma businesses into two separate companies. The company had also reported its FY03 numbers recently. Let's take a look.

Dabur: Sluggish topline, improved OPM

(Oct 30, 2002)

Dabur India, the ayurvedic products major, has reported a marginal 2% topline growth during the September quarter 2002. The company had reported a 7% topline growth during the June quarter. Cost efficiencies led to a 160 basis point expansion in operating margins, thus helping the company report nearly 24% growth in 2QFY03 net profit.

Dabur: Encouraging numbers…

(Jul 31, 2002)

Dabur India, the ayurvedic products major, has reported an encouraging 7% topline growth in June quarter. It ability to control costs led to a 100 basis point expansion in operating margins, thus helping the company report an over 30% growth in 1QFY03.

Dabur: In a trough

(Jun 12, 2002)

Slowdown and competition seems to have finally caught with Dabur Limited, India's largest ayurvedic FMCG company. In 4QFY02, the company actually reported an 8% decline in topline (the first negative in last few years). Its net profit saw a 67% decline during the said quarter.

Dabur: The pressure continues

(Feb 5, 2002)

Dabur India Limited, the ayurvedic products major, reported a marginal 1% increase in topline and a mere 2% growth in net profits during the December quarter of FY02.

Dabur: Sluggish numbers

(Nov 28, 2001)

Dabur India declared its first half FY02 results yesterday. The company reported a small 3% growth in turnover and a 13% growth in bottomline during this period. Comparing 2QFY02 with the corresponding quarter last year, Dabur managed a 5% growth in turnover and a 10% growth in net profits.

Dabur: Topline concerns

(Jul 26, 2001)

Dabur India has posted a 23% growth in 1QFY02 net profit to Rs 88 m. This growth in bottomline has come despite a negligible topline growth. Reduction of interest cost by 8% and an 11% jump in other income contributed to the company's bottomline growth.

Dabur: Improving outlook

(Jun 4, 2001)

Dabur India Limited FY01 results seem satisfactory against the backdrop of a slowdown in the FMCG sector. The company has recorded a 12% growth in net turnover during this period. Its bottomline has surged 39% (excluding extraordinary items) in FY01.

Dabur 3QFY01 net jumps 42%

(Jan 30, 2001)

Dabur India, the ayurvedic products giant has declared a 42% jump in its 3QFY01 bottomline. This surge was on the back of a 10% jump in its topline during the period.

Dabur: In the reckoning

(Aug 31, 2000)

Dabur India, the 115 year old FMCG ‘ayurvedic’ company operates in the niche natural/ayurvedic products segment with a product folio of over 500 products. But despite its range, investors have been wary of investing in this company simply because of its unrelated diversifications and a family run business.

Dabur and Zandu: Distant cousins

(May 19, 2000)

To a layman Dabur and Zandu are companies operating in the niche ayurveda segment. At first glance these companies seem alike because of their 'ayurvedic' image. But probe a little further and you find two very different entities.

Other income powers Dabur’s profit

(Apr 14, 2000)

Dabur has reported an over 53% growth in net profit for the year ended March 2000 over the previous year. The growth in sales amounted to 13.4%. A large chunk of the pre–tax profit however, is accounted for by other income (over 42%) of which Rs 201 m (i.e. 25% of pre–tax profit) is non–recurring other income. During the year the company also wrote off Rs 85 m on account of bad debts accruing from an earlier system of credit.

Dabur in talks for Zandu for possible merger

(Dec 24, 1999)

A possible merger between the two ‘Chyavanprash’ giants Dabur and Zandu is brewing. Dabur has reportedly offered the Zandu management a price of Rs. 6800-7000 per share. Both the management’s have however denied the talks.

Dabur subsidiary plans line extensions for Spirulina, new products

(Dec 23, 1999)

Dabur subsidiary Sanat Products (Sanat), manufacturers of ayurveda and herbal products under the Sunova brand name is planning a line extension for its largest-selling Spirulina range.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MARKET STATS